CoxaPro > Clinical Library > Tervetuloa Clinical Libraryyn > Rivaroxaban-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism after total knee replacement: Results of a randomized multi-center trial
The Journal of Arthroplasty, ISSN: 0883-5403, Vol: 24, Issue: 2, Page: e40

Rivaroxaban-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism after total knee replacement: Results of a randomized multi-center trial

Jay R. Lieberman; Nadia Rosencher; Frank Misselwitz
Knee

Rivaroxaban-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism after total knee replacement: Results of a randomized multi-center trial


Link to article